BioNTech to Host Innovation Series R&D Day on November 11,

MAINZ, Germany, October 28, 2025 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”), will host an edition of the Company’s Innovation Series R&D Day at 09:00 a.m. Eastern Standard Time (3:00 p.m. CET) on Tuesday, November 11, 2025 in New York City, U.S. On the day, members of BioNTech’s leadership team will provide … Read more

Solar energy is fuelling the energy

(Oslo, 28 October 2025) “Competitive renewable technologies such as solar, wind, and batteries are significantly driving the shift away from fossil fuels to renewables. Our analysis shows that the development of renewables continue at a rapid pace, with solar as a leading technology, even in a scenario of global unrest,” says Torjus Folsland Bolkesjø, Head … Read more

‘I Love This Competition’ – Eddie Howe Wants Carabao Cup Defence

NEWCASTLE UPON TYNE, ENGLAND – AUGUST 15: Newcastle United Head Coach Eddie Howe speaks to the media during the first press conference of the season at the Newcastle United Media Centre on August 15, 2025 in Newcastle upon Tyne, England. (Photo by Serena Taylor/Newcastle United via Getty Images) Newcastle United via Getty Images Newcastle United … Read more

onsemi’s Treo Platform Selected by Teledyne for Advanced

SCOTTSDALE, Ariz., Oct. 28, 2025 (GLOBE NEWSWIRE) — onsemi today announced that Teledyne Technologies has selected its Treo platform to develop next-generation readout integrated circuit (ROIC) application-specific integrated circuits (ASICs) for infrared imaging systems. As the industry’s most advanced analog and mixed-signal platform, Treo can be combined with specialized ROIC modules to meet the demands … Read more

NHS England » NHS artificial intelligence (AI) trial to diagnose prostate cancer up to a month faster

The NHS will test an AI-powered ‘one-day diagnostics’ service for prostate cancer that could transform diagnosis and save some men up to a month of waiting. The new ‘one stop shop’ pilot, funded by NHS England, will use artificial intelligence to interpret MRI scans for men with suspected prostate cancer, helping spot lesions in a … Read more

Opjustering

MEDDELELSE NR. 295 28. oktober 2025 Opjustering ChemoMetec oplever en stigende interesse for sin teknologi, herunder ikke mindst XcytoMatic platformen, og forventer som følge heraf en positiv udvikling i salg og indtjening i særligt den sidste del af regnskabsåret 2025/26. Der forventes således nu en omsætning i regnskabsåret 2025/26 på DKK 565-580 mio. mod senest … Read more